Loading chart…
PRE-MARKET
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis.
Hester Biosciences Limited (HESTERBIO) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The HESTERBIO share price is ₹2,371.40 (-0.78% today), with a market capitalisation of ₹20B and a price-to-earnings (P/E) ratio of 14.7. MarketRipple tracks the HESTERBIO investment thesis, the ripple-chain impact of market events on Hester Biosciences Limited, and the Healthcare sector outlook.
Open
₹2,421.30
High
₹2,440.20
Low
₹2,325.00
Prev. Close
₹2,390.00
52W High
₹2,683.60
52W Low
₹1,239.30
Day range
₹2,325.00–₹2,440.20
52-week range
₹1,239.30–₹2,683.60
Volume
5K
P/E
14.7
ROE
34.7%
D/E
0.54
Margin
41.1%
Hester Biosciences Limited (NSE: HESTERBIO) is currently trading at ₹2,371.40 (-0.78%).
Hester Biosciences Limited's market capitalization is ₹20B.
Hester Biosciences Limited's price-to-earnings (P/E) ratio is 14.7.
Hester Biosciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).